nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—Glucose tolerance impaired—Octreotide—thymus cancer	0.0673	0.0673	CcSEcCtD
Methylprednisolone—Diabetic—Octreotide—thymus cancer	0.0543	0.0543	CcSEcCtD
Methylprednisolone—Osteonecrosis—Octreotide—thymus cancer	0.0487	0.0487	CcSEcCtD
Methylprednisolone—Intraocular pressure increased—Octreotide—thymus cancer	0.0412	0.0412	CcSEcCtD
Methylprednisolone—Trauma—Octreotide—thymus cancer	0.0381	0.0381	CcSEcCtD
Methylprednisolone—Fracture—Octreotide—thymus cancer	0.0312	0.0312	CcSEcCtD
Methylprednisolone—Multiple fractures—Octreotide—thymus cancer	0.0312	0.0312	CcSEcCtD
Methylprednisolone—Peptic ulcer—Octreotide—thymus cancer	0.0271	0.0271	CcSEcCtD
Methylprednisolone—Neuritis—Octreotide—thymus cancer	0.0243	0.0243	CcSEcCtD
Methylprednisolone—Tingling sensation—Octreotide—thymus cancer	0.0225	0.0225	CcSEcCtD
Methylprednisolone—Petechiae—Octreotide—thymus cancer	0.022	0.022	CcSEcCtD
Methylprednisolone—Acne—Octreotide—thymus cancer	0.0215	0.0215	CcSEcCtD
Methylprednisolone—Amenorrhoea—Octreotide—thymus cancer	0.0206	0.0206	CcSEcCtD
Methylprednisolone—Arthropathy—Octreotide—thymus cancer	0.0199	0.0199	CcSEcCtD
Methylprednisolone—Neuropathy—Octreotide—thymus cancer	0.017	0.017	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Octreotide—thymus cancer	0.0152	0.0152	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Octreotide—thymus cancer	0.0145	0.0145	CcSEcCtD
Methylprednisolone—Injury—Octreotide—thymus cancer	0.0143	0.0143	CcSEcCtD
Methylprednisolone—Amnesia—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Methylprednisolone—Osteoarthritis—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Methylprednisolone—Psychotic disorder—Octreotide—thymus cancer	0.0129	0.0129	CcSEcCtD
Methylprednisolone—Irritability—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Methylprednisolone—Muscular weakness—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Methylprednisolone—Abdominal distension—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Methylprednisolone—Bronchospasm—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Methylprednisolone—Pancreatitis—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Methylprednisolone—Sweating increased—Octreotide—thymus cancer	0.0111	0.0111	CcSEcCtD
Methylprednisolone—Weight increased—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Octreotide—thymus cancer	0.00994	0.00994	CcSEcCtD
Methylprednisolone—Bradycardia—Octreotide—thymus cancer	0.00927	0.00927	CcSEcCtD
Methylprednisolone—Rhinitis—Octreotide—thymus cancer	0.00913	0.00913	CcSEcCtD
Methylprednisolone—Visual impairment—Octreotide—thymus cancer	0.00877	0.00877	CcSEcCtD
Methylprednisolone—Cardiac disorder—Octreotide—thymus cancer	0.00845	0.00845	CcSEcCtD
Methylprednisolone—Immune system disorder—Octreotide—thymus cancer	0.00822	0.00822	CcSEcCtD
Methylprednisolone—Arrhythmia—Octreotide—thymus cancer	0.00813	0.00813	CcSEcCtD
Methylprednisolone—Mental disorder—Octreotide—thymus cancer	0.00797	0.00797	CcSEcCtD
Methylprednisolone—Malnutrition—Octreotide—thymus cancer	0.00792	0.00792	CcSEcCtD
Methylprednisolone—Erythema—Octreotide—thymus cancer	0.00792	0.00792	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Octreotide—thymus cancer	0.00735	0.00735	CcSEcCtD
Methylprednisolone—Malaise—Octreotide—thymus cancer	0.00715	0.00715	CcSEcCtD
Methylprednisolone—Vertigo—Octreotide—thymus cancer	0.00712	0.00712	CcSEcCtD
Methylprednisolone—Syncope—Octreotide—thymus cancer	0.00711	0.00711	CcSEcCtD
Methylprednisolone—Loss of consciousness—Octreotide—thymus cancer	0.00696	0.00696	CcSEcCtD
Methylprednisolone—Convulsion—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Methylprednisolone—Hypertension—Octreotide—thymus cancer	0.00684	0.00684	CcSEcCtD
Methylprednisolone—Arthralgia—Octreotide—thymus cancer	0.00675	0.00675	CcSEcCtD
Methylprednisolone—Myalgia—Octreotide—thymus cancer	0.00675	0.00675	CcSEcCtD
Methylprednisolone—Anxiety—Octreotide—thymus cancer	0.00672	0.00672	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0067	0.0067	CcSEcCtD
Methylprednisolone—Discomfort—Octreotide—thymus cancer	0.00667	0.00667	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Octreotide—thymus cancer	0.00647	0.00647	CcSEcCtD
Methylprednisolone—Infection—Octreotide—thymus cancer	0.00642	0.00642	CcSEcCtD
Methylprednisolone—Shock—Octreotide—thymus cancer	0.00636	0.00636	CcSEcCtD
Methylprednisolone—Nervous system disorder—Octreotide—thymus cancer	0.00634	0.00634	CcSEcCtD
Methylprednisolone—Tachycardia—Octreotide—thymus cancer	0.00631	0.00631	CcSEcCtD
Methylprednisolone—Skin disorder—Octreotide—thymus cancer	0.00628	0.00628	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Octreotide—thymus cancer	0.00625	0.00625	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00589	0.00589	CcSEcCtD
Methylprednisolone—Insomnia—Octreotide—thymus cancer	0.00585	0.00585	CcSEcCtD
Methylprednisolone—Paraesthesia—Octreotide—thymus cancer	0.00581	0.00581	CcSEcCtD
Methylprednisolone—Dyspepsia—Octreotide—thymus cancer	0.00569	0.00569	CcSEcCtD
Methylprednisolone—Fatigue—Octreotide—thymus cancer	0.00558	0.00558	CcSEcCtD
Methylprednisolone—Feeling abnormal—Octreotide—thymus cancer	0.00533	0.00533	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Octreotide—thymus cancer	0.00529	0.00529	CcSEcCtD
Methylprednisolone—Urticaria—Octreotide—thymus cancer	0.00514	0.00514	CcSEcCtD
Methylprednisolone—Abdominal pain—Octreotide—thymus cancer	0.00511	0.00511	CcSEcCtD
Methylprednisolone—Hypersensitivity—Octreotide—thymus cancer	0.00476	0.00476	CcSEcCtD
Methylprednisolone—Asthenia—Octreotide—thymus cancer	0.00464	0.00464	CcSEcCtD
Methylprednisolone—Pruritus—Octreotide—thymus cancer	0.00458	0.00458	CcSEcCtD
Methylprednisolone—Diarrhoea—Octreotide—thymus cancer	0.00442	0.00442	CcSEcCtD
Methylprednisolone—Dizziness—Octreotide—thymus cancer	0.00428	0.00428	CcSEcCtD
Methylprednisolone—Vomiting—Octreotide—thymus cancer	0.00411	0.00411	CcSEcCtD
Methylprednisolone—Rash—Octreotide—thymus cancer	0.00408	0.00408	CcSEcCtD
Methylprednisolone—Dermatitis—Octreotide—thymus cancer	0.00407	0.00407	CcSEcCtD
Methylprednisolone—Headache—Octreotide—thymus cancer	0.00405	0.00405	CcSEcCtD
Methylprednisolone—Nausea—Octreotide—thymus cancer	0.00384	0.00384	CcSEcCtD
